Possibility of Aggravation of Tissue Sclerosis after Injection of Multipotent Mesenchymal Stromal Cells Near the Forming Cicatrix in the Experiment
- Авторы: Maiborodin I.V.1, Morozov V.V.1, Anikeev A.A.1, Figurenko N.F.1, Maslov R.V.1, Matveeva V.A.1, Chastikina G.A.1, Maiborodina V.I.2
- 
							Учреждения: 
							- Center of New Medical Technologies, Institute of Chemical Biology and Fundamental Medicine, Siberian Division of the Russian Academy of Sciences
- Laboratory of Ultrastructural Bases of Pathology, Institute of Molecular Pathology and Pathomorphology
 
- Выпуск: Том 163, № 4 (2017)
- Страницы: 554-560
- Раздел: Translated from Kletochnye Tekhnologii v Biologii i Meditsine (Cell Technologies in Biology and Medicine)
- URL: https://ogarev-online.ru/0007-4888/article/view/239085
- DOI: https://doi.org/10.1007/s10517-017-3848-1
- ID: 239085
Цитировать
Аннотация
The peculiarities of tissue sclerosis after injection of autologous bone marrow multipotent mesenchymal stromal cells transfected with GFP gene and stained with Vybrant CM-Dil cell membrane dye were studied by light microscopy with luminescence. The surgical intervention consisting in ligation of the great vein was followed by tissue sclerotic transformation caused by direct damage and chronic inflammation caused by the presence of slowly resorbed ligature. Injection of stromal cells after this intervention led to formation of more extensive scar. This can attest to the possibility of stromal cells differentiation into connective tissue cells, fibroblasts, and stimulation of proliferation and collagen synthesis by host fibroblasts. A decrease in the volume of dense fibrous connective tissue due to scar reorganization at latter terms cannot not excluded.
Об авторах
I. Maiborodin
Center of New Medical Technologies, Institute of Chemical Biology and Fundamental Medicine, Siberian Division of the Russian Academy of Sciences
							Автор, ответственный за переписку.
							Email: imai@mail.ru
				                					                																			                												                	Россия, 							Novosibirsk						
V. Morozov
Center of New Medical Technologies, Institute of Chemical Biology and Fundamental Medicine, Siberian Division of the Russian Academy of Sciences
														Email: imai@mail.ru
				                					                																			                												                	Россия, 							Novosibirsk						
A. Anikeev
Center of New Medical Technologies, Institute of Chemical Biology and Fundamental Medicine, Siberian Division of the Russian Academy of Sciences
														Email: imai@mail.ru
				                					                																			                												                	Россия, 							Novosibirsk						
N. Figurenko
Center of New Medical Technologies, Institute of Chemical Biology and Fundamental Medicine, Siberian Division of the Russian Academy of Sciences
														Email: imai@mail.ru
				                					                																			                												                	Россия, 							Novosibirsk						
R. Maslov
Center of New Medical Technologies, Institute of Chemical Biology and Fundamental Medicine, Siberian Division of the Russian Academy of Sciences
														Email: imai@mail.ru
				                					                																			                												                	Россия, 							Novosibirsk						
V. Matveeva
Center of New Medical Technologies, Institute of Chemical Biology and Fundamental Medicine, Siberian Division of the Russian Academy of Sciences
														Email: imai@mail.ru
				                					                																			                												                	Россия, 							Novosibirsk						
G. Chastikina
Center of New Medical Technologies, Institute of Chemical Biology and Fundamental Medicine, Siberian Division of the Russian Academy of Sciences
														Email: imai@mail.ru
				                					                																			                												                	Россия, 							Novosibirsk						
V. Maiborodina
Laboratory of Ultrastructural Bases of Pathology, Institute of Molecular Pathology and Pathomorphology
														Email: imai@mail.ru
				                					                																			                												                	Россия, 							Novosibirsk						
Дополнительные файлы
 
				
			 
						 
					 
						 
						 
						 
									 
  
  
  
  
  Отправить статью по E-mail
			Отправить статью по E-mail  Открытый доступ
		                                Открытый доступ Доступ предоставлен
						Доступ предоставлен Только для подписчиков
		                                		                                        Только для подписчиков
		                                					